mGluR5 mediates post-radiotherapy fatigue development in cancer patients (2018) Saligan et al.

Marco

Marco

Senior Member (Voting Rights)
mGluR5 mediates post-radiotherapy fatigue development in cancer patients

https://www.nature.com/articles/s41398-018-0161-3

In essence, a genetic vulnerability primes the immune system to an inflammatory reponse to radiotherapy in those who develop long term fatigue.

Interestingly these individuals report no fatigue issues prior to radiotherapy suggesting a 'two-hit' scenario.
 
Last edited by a moderator:
Marco said:
mGluR5 mediates post-radiotherapy fatigue development in cancer patients

https://www.nature.com/articles/s41398-018-0161-3

In essence, a genetic vulnerability primes the immune system to an inflammatory reponse to radiotherapy in those who develop long term fatigue.

Interestingly these individuals report no fatigue issues prior to radiotherapy suggesting a 'two-hit' scenario.
Click to expand...

Does this tie in with the Moreau twin study highlighted on another thread by @wigglethemouse which found gluatamate genetics differing from controls?
https://www.s4me.info/threads/machine-learning-assisted-research-on-me-cfs.5015/page-7
 
You must log in or register to reply here.
Back
Top Bottom